Cannabis Law Report

SEPTEMBER 23, 2019

Due to the Schedule I classification by the Drug Enforcement Agency (DEA), researchers seeking to investigate health effects associated with cannabis must follow a regimented application process. www.accessdata.fda.gov/drugsatfda_docs/label/2006/018677s011lbl.pdf (www.accessdata.fda.gov). Accessed August 20, 2019. www.epidiolex.com/.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Meadow

JULY 13, 2018

One of our primary goals for Meadowlands was to open the channels of communication and make sure compliance and regulatory information are available to everyone in the community who needs it, not just those who can afford compliance experts. We believe in lowering the cost of compliance through free-flowing and accurate information.

Wellness and Beauty 40

Wellness and Beauty Policy Consumption Cannabis 40

Canna Law Blog

OCTOBER 1, 2020

Olsen issued a memorandum entitled “Memorandum Opinion for the Chief Counsel, Drug Enforcement Administration” (the “ Olsen Memo ”) to the United States Drug Enforcement Administration (“DEA”). In 2006, the U.S. Presumably, these requirements provided justification for the DEA to burden these religious exemptions. Gonzales v.

History 98

History Law DEA Safety 98

Cannabis Law Report

MARCH 25, 2019

The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 9, 2006 , 120 Stat. 201, July 27, 2006 , 120 Stat. Emphasis added). 3005(a), title IV, § ?

Banking 45

Banking Law Marijuana State Laws 45